FDA.reportPublic FDA data

Lorazepam

Product NDC
70518-2239
11-digit product format
705182239
Labeler code
70518
Product ID
70518-2239_c716aa3f-909f-083d-e053-2995a90a577c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lorazepam
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA072927
Marketing category
ANDA
Marketing start
2019-07-30
Marketing end
0000-00-00
Substance
LORAZEPAM
Active strength
1 mg/1
Pharmacologic classes
Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2239-02023-03-08C16284748780-1f386c649-cc51-0266-e053-dadaa90a7c1a864c47db-1137-4154-8073-a655fab34b8c
70518-2239-22023-03-08C16284748780-1f386c649-cc51-0266-e053-dadaa90a7c1a864c47db-1137-4154-8073-a655fab34b8c
70518-2239-02023-01-30C16284748780-1f386c649-cc51-0266-e053-dadaa90a7c1a864c47db-1137-4154-8073-a655fab34b8c
70518-2239-22023-01-30C16284748780-1f386c649-cc51-0266-e053-dadaa90a7c1a864c47db-1137-4154-8073-a655fab34b8c

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2239-27051822390230 TABLET in 1 BLISTER PACK (70518-2239-2) 30 tablet2021-03-230000-00-00NoNoCurrent